Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$775.18 - $881.7 $20.9 Million - $23.7 Million
-26,900 Reduced 72.9%
10,000 $8.78 Million
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $25.6 Million - $31.2 Million
36,900 New
36,900 $30.4 Million
Q1 2023

May 15, 2023

BUY
$680.49 - $826.97 $25 Million - $30.3 Million
36,700 New
36,700 $30.2 Million
Q4 2021

Feb 11, 2022

SELL
$543.48 - $670.97 $17.9 Million - $22.1 Million
-33,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$574.03 - $680.96 $8.32 Million - $9.87 Million
14,500 Added 78.38%
33,000 $20 Million
Q2 2021

Aug 16, 2021

BUY
$472.8 - $558.54 $8.75 Million - $10.3 Million
18,500 New
18,500 $10.3 Million
Q1 2021

May 17, 2021

SELL
$446.73 - $548.2 $6.7 Million - $8.22 Million
-15,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$478.3 - $607.98 $7.17 Million - $9.12 Million
15,000 New
15,000 $7.25 Million
Q2 2020

Aug 14, 2020

SELL
$493.32 - $643.92 $12.9 Million - $16.9 Million
-26,200 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$336.18 - $494.43 $8.81 Million - $13 Million
26,200 New
26,200 $12.8 Million
Q3 2019

Nov 14, 2019

SELL
$273.46 - $318.39 $2.05 Million - $2.39 Million
-7,500 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$299.6 - $414.82 $2.25 Million - $3.11 Million
7,500 New
7,500 $2.35 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.